[1]石义兵,郭小龙△.活血定喘汤对支气管哮喘患儿气道炎症及炎性因子水平的影响*[J].陕西中医,2020,(11):1602-1606.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.023]
　SHI Yibing,GUO Xiaolong..Effects of Huoxue Dingchuan decoction on airway inflammation and inflammatory factors in children with bronchial asthma[J].,2020,(11):1602-1606.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.023]
点击复制

活血定喘汤对支气管哮喘患儿气道炎症及炎性因子水平的影响*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年11期
页码:
1602-1606
栏目:
临床研究
出版日期:
2020-11-05

文章信息/Info

Title:
Effects of Huoxue Dingchuan decoction on airway inflammation and inflammatory factors in children with bronchial asthma
作者:
石义兵1; 郭小龙2△
1.鄂东医疗集团黄石市妇幼保健院儿科(黄石 435000); 2.陕西省延安市人民医院(延安 716000)
Author(s):
SHI Yibing; GUO Xiaolong.
Department of Pediatrics,Huangshi Maternal and Child Health Hospital,Edong Medical Group(Huangshi 435000)
关键词:
活血定喘汤;  儿童哮喘;  炎性因子;  1-磷酸鞘氨醇;  磷脂酰肌醇-3-激酶;  白细胞介素13
Keywords:
Huoxue Dingchuan decoction;  Childhood asthma;  Inflammatory factors;  Sphingosine 1-phosphate;  Phosphatidylinositol-3-kinase;  IL-13
分类号:
R562.25
DOI:
DOI:10.3969/j.issn.1000-7369.2020.11.023
文献标志码:
A
摘要:
目的:探讨活血定喘汤对支气管哮喘患儿气道炎症及炎性因子水平的影响。方法:将诊断为支气管哮喘的98例患儿,随机分为研究组和对照组各49例,对照组口服孟鲁司特钠片治疗,研究组在对照组基础上联合加用活血定喘汤治疗,比较两组患儿临床治疗总有效率和不良反应发生率,肺功能改善情况,同时检测并比较两组患者治疗前后的血清炎症因子[白细胞介素13(IL-13)、白细胞介素-4(IL-4)、γ-干扰素(IFN-γ)]、免疫细胞水平[嗜酸性粒细胞直接计数(EOS)、嗜酸性阳离子蛋白(ECP)、免疫球蛋白 E(IgE)、CD4+、CD4+/ CD8+]以及血清1-磷酸鞘氨醇(S1P)、磷脂酰肌醇-3-激酶(PI3K)表达水平。结果:治疗3个月后同组患儿FEV1、FEV1/FVC以及C-ACT评分均显著高于治疗前,而研究组的改善及变化幅度明显高于对照组(P<0.05); 两组患儿治疗的有效率差异具有统计学意义(P<0.05),研究组为89.80%,明显高于对照组的65.31%; 同组患者比较,治疗后的血清炎性因子(IL-4、IL-13)、免疫细胞水平(ECP、EOS、IgE、CD8+)、S1P水平以及PI3K表达水平均显著低于治疗前,而CD4+、INF-γ和CD4+/ CD8+则高于治疗前,且与对照组相比,研究组变化更明显(P<0.05); 两组患儿不良反应发生比较,差异无统计学意义(P>0.05)。结论:活血定喘汤治疗儿童支气管哮喘临床疗效显著,可改善患儿体内血清炎症因子、PI3K以及 S1P水平,增强患儿肺功能和免疫功能。
Abstract:
Objective:To explore the effect of Huoxue Dingchuan decoction on airway inflammation and inflammatory factors in children with bronchial asthma.Methods:The subjects were 98 cases of children with bronchial asthma.All children were randomly divided into study group(49 cases)and control group(49 cases).The control group was treated with montelukast sodium tablets,and the research group was treated with Huoxue Dingchuan decoction in combination with the control group.The total effective rate of clinical treatment,incidence of adverse reactions,and improvement in lung function were compared between the two groups of children.At the same time,the serum inflammatory factors [Interleukin 13(IL-13),Interleukin-4(IL-4),γ-interferon(Interferon-γ,IFN-γ)],Immune cell level [Direct eosinophil count(EOS),Eosinophil cationic protein(ECP),Immunoglobulin E(IgE),CD4+,CD4+/ CD8+] and serum sphingosine 1-phosphate(S1P),phosphatidylinositol-3-kinase(PI3K)expression levels detected and compared.Results:After three months of treatment,the scores of FEV1,FEV1 / FVC and c-act in the same group were significantly higher than those before treatment,while the improvement and change range of the study group were significantly higher than those of the control group(P<0.05); the effective rate of treatment between the two groups was statistically significant(P<0.05),89.80% in the study group,significantly higher than 65.31% in the control group.Compared with the control group,the levels of serum inflammatory factors(IL-4,IL-13),immune cell levels(ECP,EOS,IgE,CD8+),S1P and PI3K expression levels after treatment were significantly lower than those before treatment,while the levels of CD4+,INF-γ and CD4+/ CD8+ were higher than those before treatment.Compared with the control group,the study group had more changes(P<0.05).The difference of adverse reactions between the two groups did not reach the statistical standard(P>0.05).Conclusion:Huoxue Dingchuan decoction has a significant clinical effect on children with bronchial asthma,which can significantly improve the serum inflammatory factors,PI3K and S1P levels in children,and enhance lung function and immune function.

参考文献/References:

[1] Gupta A,Gupta LK,Rehan HS,et al.Response to inhaled corticosteroids on serum CD28,quality of life,and peak expiratory flow rate in bronchial asthma[J].Allergy and Asthma Proceedings,2017,38(2):13-18.
[2] Rahman MA,Chakraborty R,Ferdousi KR,et al.New therapeutic approach to treat allergic rhinitis & bronchial asthma,considering these two as one united airway disease [J].Mymensingh Medical Journal,2017,26(1):216-223.
[3] Sonja K,Nina S,Susetta F.Th9 and other IL-9-producing cells in allergic asthma[J].Seminars in Immunopathology,2017,39(1):55-68.
[4] 郭钊明,黄楚栓,刘建博,等.难治性哮喘的中医辨治思考[J].中华中医药杂志,2019,34(7):2928-2931.
[5] Ruiz M,Frej C,Holma RA,et al.High-density lipoprotein-associated apolipoprotein limits endothelial inflammation by delivering sphingosine-1-phosphate to the sphingosine-1-phosphate receptor 1[J].Arterioscler Thromb Vasc Biol,2017,37(1):118-129.
[6] Shi HL,Liu JB,Lu AP.Expression profiles of PI3K,NF-κB,and STAT1 in peripheral blood mononuclear cells in children with bronchial asthma[J].Chinese Journal of Contemporary Pediatrics,2016,18(7):614-621.
[7] 中华医学会儿科学分会呼吸学组.儿童支气管哮喘诊断与防治指南(2016年版)[J].中华儿科杂志,2016,54(3):167-181.
[8] 张 晗,尚云晓,申昆玲,等.雾化吸入丙酸氟替卡松与口服泼尼松对儿童哮喘急性发作期有效性及安全性临床研究[J].中国实用儿科杂志,2017,32(9):708-712.
[9] 郝宏文,王 豪,王道涵,等.从伏风化燥伤阴论治儿童咳嗽变异性哮喘的体会[J].现代中医临床,2019,26(3):71-73.
[10] 夏逸飞,孙子凯.哮喘-慢阻肺重叠的中医辨治思路[J].湖南中医药大学学报,2019,39(5):619-622.
[11] 黄传君,赵方正,陈方方,等.吸入性糖皮质激素能有效控制支气管哮喘气道炎症[J].中华结核和呼吸杂志,2018,41(11):912.
[12] Lezmi G,Blic J.Assessment of airway inflammation and remodeling in children with severe asthma:the next challenge[J].Pediatric Pulmonology,2018,53(9):1171-1175.
[13] Panek M,Kuna P,Witusik A,et al.Temperament and stress coping styles in bronchial asthma patients[J].Advances in Dermatology and Allergology,2016,6(10):469-474.
[14] Jiang X,Fang L,Wu H,et al.TLR2 regulates allergic airway inflammation and autophagy through PI3K/Akt signaling pathway[J].Inflammation,2017,40(4):1-11.
[15] Prasad R,Hadjidemetriou I,Maharaj A,et al.Sphingosine-1-phosphate lyase mutations cause primary adrenal insufficiency and steroid-resistant nephrotic syndrome [J].Journal of Clinical Investigation,2017,127(3):942-953.
[16] Feuerborn R,Becker S,Poti F,et al.High density lipoprotein(HDL)-associated sphingosine 1-phosphate(S1P)inhibits macrophage apoptosis by stimulating STAT3 activity and survivin expression[J].Atherosclerosis,2017,257(1):29-37.
[17] 陈 娜,杨 滨.西红花非药用部位化学成分和药理作用研究进展[J].中国中药杂志,2018,43(14):2884-2891.
[18] 金 香,金 燕,冯晓纯,等.朝医麻黄发表汤对哮喘小鼠气道炎症的影响[J].中华中医药杂志,2019,34(7):3254-3257.

备注/Memo

备注/Memo:
*湖北省卫生健康委员会资助面上项目(WJ2017M210)
更新日期/Last Update: 2020-11-09